Stavudine
Alternative Names: BMY 27857; d4T; Zerit; ZeritavirLatest Information Update: 12 Dec 2025
At a glance
- Originator Bristol-Myers Squibb; Yale University; Yamasa Corporation
- Developer Bristol-Myers Squibb; Tanabe Pharma Corporation; Yamasa Corporation
- Class Antiretrovirals; Deoxyribonucleosides; Dideoxynucleosides; Pyrimidine nucleosides; Small molecules
- Mechanism of Action Nucleoside reverse transcriptase inhibitors
-
Orphan Drug Status
No
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Marketed HIV-1 infections